| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/17/2011 | US7943665 Anticancer agents based on regulation of protein prenylation |
| 05/17/2011 | US7943660 Inhibitors of the LFA-1/ICAM-1 interaction and uses thereof |
| 05/17/2011 | US7943636 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943610 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 05/17/2011 | US7943603 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 05/17/2011 | US7943595 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 05/17/2011 | US7943593 Compositions comprising inhibitors of IMPDH enzyme |
| 05/17/2011 | US7943583 2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods cosmetics containing compositions comprising it |
| 05/17/2011 | US7943576 Methods of using enterostatin as inhibitor of angiogenesis |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943332 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | US7943144 Herpes simplex virus complex |
| 05/17/2011 | CA2582722C Intestinal polyp inhibitor |
| 05/17/2011 | CA2576069C Detoxifizyme with activity of transforming aflatoxin and the gene encodes thereof |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2484374C Medical products comprising a haemocompatible coating, production and use thereof |
| 05/17/2011 | CA2463552C Treatment of neurodegenerative diseases and cancer of the brain |
| 05/17/2011 | CA2453418C Variolin derivatives and their use as antitumor agents |
| 05/17/2011 | CA2437994C Crystalline forms of pyrimidine nucleoside derivative |
| 05/17/2011 | CA2431274C Atp-dependent bioluminescence method and kit for detecting protein kinases |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2402446C 1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor activity |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/17/2011 | CA2308007C Enhancer for antibody to lymphocytic tumors |
| 05/12/2011 | WO2011057220A2 Compositions and methods for treating lymphoma |
| 05/12/2011 | WO2011056957A2 Enzyme inhibiting compounds |
| 05/12/2011 | WO2011056939A1 Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives |
| 05/12/2011 | WO2011056764A1 Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
| 05/12/2011 | WO2011056721A2 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 05/12/2011 | WO2011056652A1 Imidazole derivatives as ido inhibitors |
| 05/12/2011 | WO2011056566A2 Compounds and methods for treatment of cancer |
| 05/12/2011 | WO2011056502A1 Bone morphogenetic protein receptor type ii compositions and methods of use |
| 05/12/2011 | WO2011056497A1 Activin receptor type iib compositions and methods of use |
| 05/12/2011 | WO2011056494A1 Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations |
| 05/12/2011 | WO2011056477A2 Methods for treating inflammation and oxidative stress related diseases |
| 05/12/2011 | WO2011056234A1 Treatment for radiation-induced disorders |
| 05/12/2011 | WO2011056037A2 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts |
| 05/12/2011 | WO2011056021A2 Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis |
| 05/12/2011 | WO2011055991A2 A novel myxobacteria strain and a method for preparing epothilone using the same |
| 05/12/2011 | WO2011055869A1 Compositions for treatment and prevention of diabetic complications using osteomeles schwerinae |
| 05/12/2011 | WO2011055843A1 Retinoid compound |
| 05/12/2011 | WO2011055838A1 Compound for inhibiting biosynthesis of testosterone |
| 05/12/2011 | WO2011055324A1 Synhetic immunogenic glycoconjugate for melanoma immunotherapy |
| 05/12/2011 | WO2011055320A1 Imidazopyridine derivatives |
| 05/12/2011 | WO2011055215A2 Novel kinase modulators |
| 05/12/2011 | WO2011055142A2 1,4-quinones and their sulfur analogues useful as ligands of n-acetyltransferases |
| 05/12/2011 | WO2011055115A1 Akt / pkb inhibitors |
| 05/12/2011 | WO2011054939A2 Compositions and methods for inhibiting expression of kif10 genes |
| 05/12/2011 | WO2011054875A1 Pharmaceuticals containing choline |
| 05/12/2011 | WO2011054848A1 Thetrahydroquinolines derivatives as bromodomain inhibitors |
| 05/12/2011 | WO2011054846A1 Imidazo [4, 5-c] quinoline derivates as bromodomain inhibitors |
| 05/12/2011 | WO2011054845A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | WO2011054844A1 Condensed azepine derivatives as bromodomain inhibitors |
| 05/12/2011 | WO2011054841A1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 05/12/2011 | WO2011054837A2 Bifunctional prodrugs and drugs |
| 05/12/2011 | WO2011054828A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 05/12/2011 | WO2011054811A1 Rna antagonists targeting hsp27 combination therapy |
| 05/12/2011 | WO2011054553A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | WO2011054525A1 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds |
| 05/12/2011 | WO2011054433A1 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 05/12/2011 | WO2011054289A1 Epirubicin derivatives |
| 05/12/2011 | WO2011054190A1 Melonine bisindole compounds, pharmaceutical compositions, preparation method and use thereof |
| 05/12/2011 | WO2011054179A1 Crystalline form of cladribine and process for preparation thereof |
| 05/12/2011 | WO2011054171A1 Tyrosine derivative histone deacetylases inhibitors and applications thereof |
| 05/12/2011 | WO2011054112A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | WO2011054030A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | WO2011034834A3 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 05/12/2011 | WO2011006084A3 Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| 05/12/2011 | WO2011005473A9 Methods for treating or preventing fatigue |
| 05/12/2011 | WO2010151710A3 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof |
| 05/12/2011 | WO2010151541A8 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 05/12/2011 | WO2010151517A3 Antigen-specific long-term memory t-cells |
| 05/12/2011 | WO2010150098A3 Use of quingolide in the treatment of endometriosis, pain and cancer |
| 05/12/2011 | WO2010148138A3 Camptothecin derivatives |
| 05/12/2011 | WO2009140621A8 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | WO2008079988A9 Quinazolines for pdk1 inhibition |
| 05/12/2011 | US20110113497 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 05/12/2011 | US20110112464 Meso-substituted porphyrins |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112279 Compositions and Methods Relating to STOP-1 |
| 05/12/2011 | US20110112199 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112180 Novel stat3 pathway inhibitors and cancer stem cell inhibitors |
| 05/12/2011 | US20110112176 Compositions and methods for inhibiting expression of kif10 genes |
| 05/12/2011 | US20110112174 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112173 Methods and compositions involving microrna |
| 05/12/2011 | US20110112164 Novel polymorphs and processes for their preparation |
| 05/12/2011 | US20110112163 Cbi derivatives subject to reductive activation |
| 05/12/2011 | US20110112155 Methods for treating cancer in patients having breast cancer resistance protein overexpression |
| 05/12/2011 | US20110112152 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
| 05/12/2011 | US20110112151 Compound capable of inhibiting 11-beta hydroxysteriod dehydrogenase |
| 05/12/2011 | US20110112149 Epothilone analogues, their pharmaceutical compositions, their use and their prepa rations |
| 05/12/2011 | US20110112144 Methods of preparing substituted heterocycles |